Low Level Laser Light Therapy and Chronic Neck and Shoulder Pain

Erchonia

Status: Completed

Conditions: Musculoskeletal Pain; Shoulder Pain; Musculoskeletal Strain; Neck Pain; Musculoskeletal Sprain

Treatments: Device: Erchonia PL2000; Device: Placebo laser

Study type: Interventional

Funder types: Industry

Identifiers

NCT00929305

ECP-002

Details and patient eligibility

About

The purpose of this study was to determine whether the application of low level laser light therapy to the neck and shoulder region is effective in reducing chronic neck and shoulder pain of musculoskeletal origin.

Full description

Chronic neck and shoulder pain arising from osteoarthritis, chronic muscle spasms or thoracic or cervical spine sprain strain can be seriously debilitating. Currently available treatment options such as pain relief medication, ice pack, massage, physical therapy and chiropractic are typically of limited effectiveness. More permanent options such as surgery are invasive with long recovery periods and side-effects and complications of their own. Low level laser light therapy, with its proven anti-inflammatory ability, offers a simple non-invasive option for the reduction of chronic neck and shoulder pain.

Enrollment: 100 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Location of pain is on the right and/or left side of the neck and/or shoulder and/or the back of the neck.
• Etiology of pain is osteoarthritis/Degenerative Joint Disorder (DJD); chronic muscle spasms or cervical and thoracic spine sprain strain, determined according to subject medical history, medication use history, previous records review, physical examination of the cervical spine and shoulder.
• Stage of injury is chronic, having prevailed for longer than 30 days.
• Degree of Pain self-rating of 50 or greater on the 0-100 Visual Analog Scale (VAS).
• 18-65 years.

Exclusion criteria

• Stage of injury is acute, having prevailed for less than 30 days.
• Known herniated disc injury.
• Any other disease or condition that may cause or contribute to the chronic pain condition.
• Presence of infection or open wound at the treatment areas.
• Use of steroids or narcotics.
• Use of over-the-counter (OTC) medication for the relief of pain within the 24-hour period prior to participating in the treatment phase of the study, or prescription medication for the relief of pain within the 48-hour period prior to participating in the treatment phase of the study.
• pregnant or lactating.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

100 participants in 2 patient groups, including a placebo group

Placebo laser

Placebo Comparator group

Description:

inactive laser light

Treatment:

Device: Placebo laser

Erchonia PL2000

Active Comparator group

Description:

The Erchonia PL2000 Laser emits 1 milliWatt (mW) of red (635nm wavelength) light via an electric diode energy source. It is a hand-held device that uses rechargeable batteries or a separate power adapter.

Treatment:

Device: Erchonia PL2000